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A B S T R A C T   
The SARS-CoV-2 pandemic has affected communities, populations, and countries throughout the world. As the 
SARS-CoV-2 pandemic developed, the extent to which the disease interacted with already existing endemic, non- 
communicable and infectious diseases became evident, hence deeply influencing health outcomes. Additionally, 
a synergistic effect has been demonstrated also with socio-economic, cultural, and contextual determinants of 
health which seem to contribute to poorer health and accumulating social disadvantages. 
In this essay, using as a starting point the syndemic theory that translates the cumulative and intertwined 
factors between different epidemics, we argue that the SARS-CoV-2 is a one health issue of a syndemic nature and 
that the failure to acknowledge this contributes to weakened policy-making processes and public health re-
sponses and ineffective health policies and programs.   
1. Background 
The SARS-CoV-2 infection was declared a public health emergency of 
international concern on 31st January and a pandemic on 11th March 
2020. The disease was first reported in China in December 2019, 
although there is evidence from Italy and France that it was already 
circulating in Europe before that time [1]. In less than four months, the 
virus spread to all continents (excepting Antarctica), creating multiple 
asynchronous national epidemics of COVID-19 [2,3]. 
The pandemic infection caused by SARS-CoV-2 is unquestionably a 
one health issue due to the high possibility that the virus has crossed the 
species barrier to infect humans, then causing human-to-human trans-
mission. Thus, there is a need to recognize the interconnection between 
people, animals, and their shared environment, and develop appro-
priate, collaborative and multidisciplinary approaches for its control 
and mitigation [4,5]. 
One perspective to the one health characteristics of the SARS-CoV-2 
infection pandemics is its human-focused syndemic “side”. 
In this essay we argue that the failure to consider the syndemic na-
ture of this pandemic contributed to weakened policy-making processes 
and public health responses. 
This essay is supported by a narrative review of the literature using a 
“synthesis of better evidence” approach [6] on syndemic theory and 
emerging evidence of the syndemic nature of the SARS-CoV-2 pandemic. 
2. Syndemic theory 
The 1990s saw the introduction of an innovative approach to 
comprehend health as part of a biocultural-synthesis that encompasses 
(i) the “determinant interconnections among pressing health problems”, 
(ii) “sufferer and community understandings of illness(es)/disease(s)” 
and (iii) the “relevant social, political, and economic forces in play”, as 
well as (iv) the environmental conditions that may lead to the devel-
opment of health or disease. This dialectical thinking led to the term of 
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“syndemic” as a new concept in epidemiological and public health 
thinking [7–12]. 
The syndemic model shares the ecological premises of the fields with 
long tradition in health research and intervention (e.g. health promo-
tion), which claim the need to overcome dichotomic understandings of 
individual behavior and social determinants, and between social and 
natural factors and further ties the syndemic model theory in with One 
Health. Consequently, the model discards conventional understandings 
of diseases as discrete entities distinct from each other and independent 
of the social contexts in which they are found. The model builds on a 
biosocial complex of co-occurrence and synergistic interaction, or 
simultaneous occurrence of diseases and their determinants that pro-
mote and enhance the overall negative effects on health and other 
conditions experienced by individuals and populations [13]. As such, it 
integrates and builds on concepts emerging concurrently, namely, 
biosocial models of health determinants [14], salutogenesis [15,16], late 
life compression of morbidity [17] and life course epidemiology 
[18–21]. 
POLICY ENVIRONMENT AND RESPONSES: Health care-seeking behavior is negavely affected by Government recommendaons that people 
remain at home and only seek health services in cases of suspected symptoms of COVID-19 and aer telephone advice; closure of borders and interrupon 
of air traffic aggravated purchase of much needed equipment. Sustainable responses require respect for public health principalism, recognion of the 
importance of the concept of “health in all policies” and adopon of a Sustainable Development Goals’ framework in the soluons adopted.
SOCIAL ENVIRONMENT:
Culture, values and norms
Ethnic idenficaon/race
Social status: gender, educaon, 
income, occupaon, standard of 
living, sgmazaon, security/fear




Health care & social care systems
Naonal health research systems
Social distancing;
Systems resilience and capacity, 




Epistemological focus: biology, diversity, 
pathogenesis, immunogenicity, clinical 
manifestaons, epidemiology …
BIOTIC ENVIRONMENT:
Suscepbility of human host: 
genecs, sex, age, nutrional 
status, behaviors and lifestyles, 
non-communicable diseases, 
including mental health;
Zoonoc manifestaons of the 
infecon;
Exposure to other 
microorganisms including live 
vaccines.
Individual and populaon-based primary, 
secondary, terary and quaternary prevenon;







Sustain gains in polluon control and climate 
change agenda due to the pandemic;
Prevent extensive polluon associated with wide 
use of protecve equipment;
Effecve risk communicaon.
Fig. 1. Social, environmental and political determinants affect the syndemics of health and disease applied to the SARS-CoV-2 Syndemic.  
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Further research on syndemics has underscored (i) a need to focus on 
social inequality as a root cause of syndemic interactions, and (ii) that 
population-level disease prevention can only occur through addressing 
the large-scale social forces that shape both individual and population 
health [22–24]. 
The term syndemic, at its simplest level, refers to two or more epi-
demics interacting synergistically and contributing, as a result of their 
interaction, to the clustering of excess burden of disease in a location or 
population, more than just the sum of both [25]. 
The syndemic concept also assumes biological synergisms that may 
vary from changes in blood biochemical markers or damage to organ 
systems caused by one pathogenic agent facilitating the spread of or 
impact on another agent, to gene mixing among pathogenic agents 
[25,26]. 
Lastly, the term syndemic also emphasizes the relevance of biological 
(hereditary factors, nutritional status, sex, age), social (wealth and 
poverty; culture and practices; networks and communities; economic, 
educational, dietary and leisure activities and behaviors; health care and 
social support systems; stigma and discrimination), environmental 
(natural and built environments) and political factors in the health of 
individuals and populations. Stress is a common pathway through which 
these social, environmental and political determinants affect the syn-
demics of health and disease (Fig. 1) [26]. 
The syndemic framework has been applied over the years to under-
stand the dynamics of migrant health, health disparities, malnutrition, 
violence (including intimate partner violence), sexual health, substance 
abuse, mental health, oral health, HIV/AIDS, tuberculosis and other 
infectious diseases, and non-communicable diseases (NCD) (such as 
diabetes mellitus, cardiopulmonary conditions, obesity or kidney dis-
ease) [22,25–41]. 
The theory of syndemics is a conceptual tool in population health 
sciences that has the potential to help policymakers and program im-
plementers in their endeavors to improve the health of populations. As 
originally theorized, three concepts underlie the theory: disease con-
centration, disease interaction, and the large-scale social forces that give 
rise to them. As theorized, syndemics are a complex, multilevel phe-
nomenon. What makes the theory most noteworthy are its predictions 
about how interactions between different epidemics amplify the disease 
burden in a manner that differs if each disease would have been expe-
rienced separately. Additionally, the theory allows predictions about 
how public health planners can (or cannot) effectively intervene to 
mitigate this burden [24]. In short: syndemic translates the cumulative 
factors between different epidemics. 
3. Evidence of the syndemic nature of the SARS-COV-2 pandemic 
The SARS-CoV-2 epidemics overlaps with endemic diseases [NCD, 
malaria, schistosomiasis, tuberculosis, hepatitis C, HIV, dengue and 
other neglected tropical diseases (NTD)] and with seasonal diseases 
(such as influenza and other respiratory diseases), a host of cultural and 
social determinants (fear, stigmatization, racism, gender, economic in-
equalities, mis-information, risk behaviors, food and nutrition insecu-
rity, occupation, climate, exposure to different types of pollution, supply 
of health and social care services, health care seeking behavior and 
violence, supply of drugs and addictive behaviors) and climate and 
environment [31,42–57] (Fig. 1). 
A spatial overlap of high rates of NCD and COVID-19 suggests a 
broader syndemic health burden, in the sense that comorbidities inter-
sect with nutrition, race and social determinants of health [56,58–60]. 
Substantial evidence points towards NCD being a major factor for poor 
outcomes resulting from COVID -19 [61,62] and vice-versa, COVID-19 
leads to the neglect of NCD [61]. 
Biological interactions between SARS-CoV-2 infection and other 
coinfecting pathogens are also relevant. First, because of changes in host 
pathology related to indirect immune effects [63]. There are many ex-
amples of important interactions between malaria, NTD and other 
infectious diseases: malaria plays a role in Epstein–Barr virus infection, 
leading to Burkitt lymphoma [64]; several parasite – HIV coinfections 
are associated with increased HIV viral load, transmission and worsened 
immunosuppression [65–67]; deworming is associated with decreased 
HIV viral load and improved CD4+ counts among HIV-infected in-
dividuals [63]. 
Studies suggest that the balance between innate immunity and ac-
quired immunity can be challenged by parasitic infections (e.g., 
parasite-induced disturbances to the helper cell type 1/type 2 balance 
and/or macrophage phenotype) and that effects of co-infections are 
immune-mediated. It has also been shown that these infections can 
affect disease susceptibility and pathogenesis and even interfere with 
accurate diagnose [68]. 
Hence it is possible that preexisting infection with tropical parasites 
and other NTDs may also lead to changes in susceptibility and/or 
severity of COVID-19, but it is unclear whether the resulting immune 
response will be beneficial or harmful when hosts are coinfected with 
SARS-CoV-2. It is worth mentioning the line of research that is looking at 
the nonspecific effects of BCG by studying the interplay between the 
prevalence of COVID-19 and the BCG vaccination and the hypothetical 
immunomodulatory effect of the BCG vaccine applied to the infection by 
the SARS-CoV-2 [69]. 
Actually, the low intensity and lethality of the national epidemics in 
most African countries suggest hypothetical protective interactions of 
the high burden of tuberculosis (and/or BCG coverage) and tropical 
parasitic diseases, along with the lack of health-care infrastructure 
capable of clinically detecting and confirming COVID-19 cases, the 
implementation of social distancing and hygiene, international air 
traffic flows, the climate, the relatively young and rural population, the 
genetic polymorphism of the angiotensin-converting enzyme 2 receptor, 
cross-immunity and the use of antimalarial drugs [70–80]. However, the 
detection of a new variant of the SARS-CoV-2 in South Africa (variant 
501Y⋅V2) in middle December 2020 with preliminary studies suggesting 
that the variant is associated with a higher viral load, which may suggest 
potential for increased transmissibility, might challenge the low trans-
missibility, low lethality trend observed so far in most African Countries 
[81]. 
There are significant concerns that the emergence of COVID-19 is 
currently overlapping with other circulating viruses, particularly 
dengue, in various endo-epidemic regions across South America, South 
East Asia and Africa. The situation warrants observations and moni-
toring as both conditions may potentially lead to fatal outcomes, espe-
cially in patients with chronic comorbidities. Also, overlapping 
infections and co-occurrence may increase the number of patients 
requiring intensive care and mechanical ventilation, overwhelming the 
capacity of health services [82,83]. 
On the other hand, there is also evidence that non-pharmaceutical 
control measures (e.g., social distancing, school closures, travel re-
strictions, use of masks) being taken may prevent or postpone the 
occurrence of seasonal infections caused by virus such as influenza and 
respiratory syncytial virus. A buildup of susceptibility during these 
control periods may result in out of season peaks or in larger outbreaks 
in the coming years [84]. 
Non-pharmaceutical interventions also negatively affect many eco-
nomic sectors, particularly in the informal economic sector (e.g., street 
vendors, informal traders), proximity economic activities, liberal 
workers and economic activities where the value chain is most depen-
dent on the mobility of goods and people [85]. These include, for 
example, animal production and its related industries. Indeed, with the 
cessation of imports and exports between countries, it is not possible to 
provide feeds that are considered as basic raw materials in livestock 
raising. This situation impairs animal movements, decreases production 
inputs availability and negatively affects animal welfare. The sustain-
ability of animal production is also affected by a shortage of workers due 
to the lockdown/curfew and the strong decrease in the purchasing 
power of the consumer. The result of the impact of non-pharmaceutical 
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interventions, namely, lockdown, restrictions to movement of people 
and goods and physical distancing, among others, may result in eco-
nomic collapse, increased unemployment, poverty deterioration and 
widespread famines, as food security becomes a global concern [86–99]. 
Stress and fear are likely to potentiate many of the interactions 
already cited. The epidemic of fear is well described by Delgado et al. 
and by Robalo et al. [100,101]. Fear in association with epidemics and 
pandemics has been acknowledged for centuries [102]. The peculiar 
aspect in relation to COVID-19 is that fear is as much caused by the 
novelty of the SARS-CoV-2 as it stems from the lack of preparedness of 
scientific communities and policymakers to help the populations to 
manage it [103,104]. 
Fear can lead to denial, including of scientific knowledge, and 
violence against neighbors and health care workers [105–107]. Fear is 
associated with social isolation, which is desirable to curtail the trans-
mission of the infectious agent but impacts negatively the mental health 
of individuals [107] and facilitates intimate partner and child violence: 
social isolation contributes to unprotecting the victim and making 
escape, requesting help and reporting of violence difficult [27,30,32]. 
Fear is behind much of the stigmatization observed in association with 
infected persons and their contacts [108]. Fear influences health-seeking 
behavior in a negative way, resulting in avoidance of contact with health 
care facilities for preventive, promotive and treatment health care 
[61,109]. Fear leads also to the abandonment of the household 
[110,111] and to disruptive consumption patterns: one of the most 
immediate impacts of COVID-19 was a wave of panic buying by the 
public as lockdowns were announced [112]. 
The perception of a medical urgency is affected, leading to avoidance 
of emergency health care services [109]. This is further aggravated by 
the redeployment of scarce resources to the medical care of COVID-19 
patients and to the reinforcement of public health teams involved with 
case finding, contact tracing and enforcement of non-pharmaceutical 
public health interventions [113,114]. 
Neglect of routine and emergency care is a reality that potentiates 
the negative effects of the SARS-CoV-2 pandemic. Government regula-
tions, particularly at the beginning of the epidemics, usually recom-
mended that people remained at home and only seek healthcare 
services, preferably through an initial telephone contact. With these 
restrictions, negative impacts on health were soon felt: endemic diseases 
such as malaria were neglected; chronic conditions worsened; women 
were left without access to family planning services, prenatal surveil-
lance consultations, vaccinations or nutritional counseling, and institu-
tional births were reduced considerably, associated in many developing 
countries with lack of public transport, leading to increases in mortality 
amenable to health care [24,29]. This situation, which accentuated the 
weaknesses of health systems and compromised the provision of ser-
vices, is like a “triple burden of disease” [26] and contributed for an 
unwelcome “third wave” [29]. 
The relationship between COVID-19 and environmental factors is 
complex [78,115]. Recent studies have demonstrated a positive corre-
lation between spread and decay of SARS-CoV-2 and temperature, ab-
solute humidity and population density [116] and a positive correlation 
between the transmissibility of the SARS-CoV-2 and lower UV radiation, 
lower latitudes, lower elevation, and smaller populations with historical 
air pollution exposure [117]. No association was detected between 
deaths and country temperature or precipitation [118]. There are also 
preliminary findings attributing a significant fraction of worldwide 
COVID-19 mortality to anthropogenic air pollution [57]. On the other, a 
strong reduction of air pollution was identified in many locations during 
the lockdown measures [119–122]. Studies measuring changes in air 
pollution and mortality have been related to a reduction in excess deaths 
due to air pollution (>4600 deaths in China, [119]. This can be viewed 
as a health co-benefit from the containment measures, which may 
reduce air pollution-induced COVID-19 mortality. Such benefits could 
also be achieved after the COVID-19 lockdown. Both perspectives of air 
pollution during the pandemic underscore the important role of fossil 
fuel-related and other anthropogenic emissions. 
There is also evidence of SARS-CoV-2 viral RNA detectable in the 
inflow but not in the outflow wastewaters and its infectivity seems null 
[123]. 
An infodemic of fake news campaigns have significantly contributed 
for all the above, by disseminating misleading information and risk 
communication strategies, incoherent messages between politicians, 
public health authorities and scientists and an information overload that 
reduces trust and confidence, compromise economic activities and fail to 
mobilize the wider level of public support needed to enforce control 
measures effectively [30,31,124]. 
4. Conclusions 
SARS-CoV-2 brought back to the forefront of the health policy debate 
significant issues already identified in past pandemics. Pledges were 
made then that we would learn from previous outbreaks and be better 
prepared when faced with another. That such has not happened and we 
are once again discussing predictable issues previously identified - such 
as health systems fragility and lack of resilience, inadequate surge ca-
pacities, and poor communication - is on the one end a moral failure 
[125] and, on the other, a reflection of the inadequate framework used 
to understand and respond to pandemics demonstrating the lack of 
preparedness for globally catastrophic risks [126]. It also identifies that 
the lack of capacity for governance is not a problem limited to low- and 
middle-income countries but widespread at all levels of development, 
highlighting the inability to correspond to the expectations created by 
the Sustainable Development Goals (SDG), of ministries exercising 
leadership beyond narrow sectoral boundaries, in pluralistic and mul-
tisectoral milieus, and also to predict and be prepared for emergent and 
future challenges while continuing to manage public services and in-
stitutions [127]. 
The interconnectivity of humans, animals and the social and abiotic 
environment (Fig. 1) is also highlighted by the current pandemic and it 
is most relevant in understanding and tackling any threats to food sys-
tems, agricultural production and other systems of economic livelihood. 
This is particularly important in economic systems where animals play 
an important role for society and food security – providing, income, 
transport, fuel and clothing as well as food, highlighting the relevance of 
a One-Health understanding of the pandemic [128]. 
The focus on finding a response to the COVID-19 pandemics, which 
should have been thought of previously (since for a long time, it was a 
given fact that a new epidemic would strike) led to a blurred approach to 
all other prevalent health issues and problems reflecting the “curse of 
piecemeal perspectives” and “siloed frameworks” [129,130]. 
Co-existent endemicendemic, and epidemic, NCD, NTD, and other 
(human and animal) infectious diseases as well as social systems’ fra-
gilities, long neglected environmental challenges, the level of health 
literacy and cultural issues were not considered and, now, the challenges 
loom larger than before as COVID-19 interacts syndemicaly with all 
these issues. 
Understanding the impact of this syndemic requires first and fore-
most learning from documented experiences. Second, it requires the use 
of theoretical frameworks that can sufficiently conceptualize its multi- 
level, interacting and dynamic nature. It implies a need for assessment 
of how the public health system and communities can better respond to 
syndemics. Thus, we advocate for the adoption of a syndemic policy 
approach that enables a holistic and distinctive understanding of the 
intersection of prevalent (endemic) diseases and COVID-19-specific 
vulnerabilities and disparities experienced by individuals, populations, 
communities and societies. Syndemic-informed approaches can then, 
supported by insightful application of public health principalism [103], 
lead to impactful multi-level prevention strategies that simultaneously 
tackle both (endemic) diseases and their determinants, and COVID-19- 
specific factors and outcomes that lead to the clustering of health vul-
nerabilities and disparities over time (Fig. 1). This more holistic 
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approach would integrate other conceptual frameworks such as “one 
health”, “health in all policies” and assume a SDG framework in the 
solutions adopted [113,131–134]. 
These frameworks would contribute to (i) an approach which tran-
scends geopolitical boundaries, based on good science, transparent 
communication and widespread global solidarity: (ii) tackle the transi-
tion out of market closures and lockdowns; (iii) more integrated and 
transparent surveillance infrastructures and monitoring of the occur-
rence of infectious diseases in humans, animals; (iii) environmental 
surveillance as an early warning system that monitors the levels of 
pathogens circulating in the population, identifies outbreaks, even 
before cases are notified to the healthcare system, and agents sharing 
similar genotypes across species as well as spatio-temporal spread of 
such infections; (iv) scrutiny of data, information, models and the pro-
cesses by which the decisions are made and their rationale; (v) improve 
coordination and active collaboration among stakeholders representing 
diverse and apparently incompatible domains; (vi) highlight the need 
for an effective institutional landscape (national, regional and global), 
facilitating adequate regulation of hotspots for transmission of infec-
tious agents among abiotic environment, animals and humans – regional 
Blocs such as the European Union, African Union, Association of 
Southeast Asian Nations, Caribbean Community and Mercado Común del 
Sur (MERCOSUR) should increase their role in health; (vii) emphasize 
the need for equitable solutions to infectious disease challenges, 
ensuring that policy response mechanisms and interventions are 
reflective of the disproportionate disease burdens borne by vulnerable 
and marginalized populations, or by persons providing health care and 
other essential services to those sick; (viii) further blur the border be-
tween infectious and NCD and between human and animal health 
encouraging an integrated approach to planetary health aligned with the 
SDG; and (ix) combine the short term approach in response to the crisis 
with a long term vision provided by the SDG. 
Despite the widely recognition that the SARS-CoV-2 pandemic has 
become a learning opportunity, as we enter the “second epidemiological 
wave” much is still to be learned and one wonders if the way society 
deals with co-existing health problems is ever going to change. The 
SARS-CoV-2 has unraveled the complex dynamics between a novel, 
challenging health problem, co-existing, chronic and endemic ones and 
the capital of knowledge, competencies and practices of people all over 
the world and stressed its fundamental syndemic nature. As such, in this 
and incoming epidemics a syndemic understanding of health and disease 
is needed. 
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[87] N.M. Hashem, A. González-Bulnes, A.J. Rodriguez-Morales, Animal welfare and 
livestock supply chain sustainability under the COVID-19 outbreak: an overview, 
Front. Vet. Sci 7 (2020), https://doi.org/10.3389/fvets.2020.582528. 
[88] H. Al-Khalaifah, A. Al-Nasser, N. Abdulmalek, H. Al-Mansour, A. Ahmed, 
G. Ragheb, Impact of SARS-Con-V2 on the poultry industry in Kuwait: a case 
study, Front. Vet. Sci 7 (2020), https://doi.org/10.3389/fvets.2020.577178. 
[89] H.M. Hafez, Y.A. Attia, Challenges to the poultry industry: current perspectives 
and strategic future after the COVID-19 outbreak, Front Vet Sci 7 (2020), https:// 
doi.org/10.3389/fvets.2020.00516. 
[90] M.C. Schippers, For the greater good? The devastating ripple effects of the Covid- 
19 crisis, Front. Psychol. 11 (2020), https://doi.org/10.3389/ 
fpsyg.2020.577740. 
[91] L.M. Neff, Hidden hunger: food insecurity in the age of coronavirus, Am. J. Clin. 
Nutr. 112 (2020) 1160–1161, https://doi.org/10.1093/ajcn/nqaa279. 
[92] E. Asiedu, S.S. Sadekla, G.A. Bokpin, Aid to Africa’s agriculture towards building 
physical capital: empirical evidence and implications for post-COVID-19 food 
insecurity, World Dev. Perspect. 20 (2020) 100269, https://doi.org/10.1016/j. 
wdp.2020.100269. 
[93] C. Gundersen, M. Hake, A. Dewey, E. Engelhard, Food Insecurity during COVID- 
19, Appl Econ Perspect Policy (2020), https://doi.org/10.1002/aepp.13100. 
[94] A. Ayanlade, M. Radeny, COVID-19 and food security in sub-Saharan Africa: 
implications of lockdown during agricultural planting seasons, Npj Sci. Food. 4 
(2020) 13, https://doi.org/10.1038/s41538-020-00073-0. 
[95] V. Erokhin, T. Gao, Impacts of COVID-19 on trade and economic aspects of food 
security: evidence from 45 developing countries, Int. J. Environ. Res. Public 
Health 17 (2020) 5775, https://doi.org/10.3390/ijerph17165775. 
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